Biopsy devices market to reach USD 3.96 billion by 2029

Data Bridge Market Research has recently published a Report, titled, “Biopsy devices market” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. In this competitive market place, businesses are always in effort to seek better solutions in terms of product trends, future products, marketing strategy, future events, actions or behaviours. The first class Biopsy Devices market research report provides strategically analyzed market research analysis and observant business insights into the most relevant markets of the clients. SWOT analysis is performed while generating this market report along with many other standard steps of researching, analysing and collecting data. When biopsy Devices report goes along with right tools and technology, it also helps tackle the uncertain challenges for the business.

An international biopsy Devices market research report is a verified source of data and information that offers a telescopic view of the current market trends, situations, opportunities and status of the biopsy devices industry. This market document also covers strategic profiling of major players in the market, meticulously analyzing their core competencies, and drawing a competitive landscape for the market. Key players and brands are analysed with respect to their actions such as developments, product launches, acquisitions, mergers, joint ventures and competitive research in the market. In addition, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the winning Biopsy Devices market report.

Biopsy devices market was valued at USD 3.67 billion in 2021 and is expected to reach USD 3.96 billion by 2029, registering a CAGR of 7.3% during the forecast period of 2022-2029. The “Breast biopsy” accounts for the largest application segment in the biopsy devices market within the forecasted period owing to the surging prevalence of breast cancer and growth in awareness about the disease. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Biopsy is a medical procedure that evaluates and removes cancerous tissue from the body. When a patient is suspected of having cancer, the test is utilized to obtain tissue samples for illness diagnosis. Cancer diagnosis includes skin biopsy, vacuum biopsy, incision and excision biopsy, needle biopsy, fine needle aspiration, and shave biopsy.

Over, the years, the burden of various types of cancer has significantly increased. Cancer accounted for nearly 10 million deaths across the globe, in 2020. Surging cases of various types of cancers globally is further resulting in increased demand for effective treatment and rising awareness regarding the availability of diagnostic and screening procedures. Owing to the extensive applications of biopsy devices, the demand for these devices will substantially growth over the forecasted period.

Recent developments,/p>

• In June 2021, Biocept, Inc., a leading provider of molecular diagnostic assays, products, and services, announced a partnership with Quest Diagnostics to offer laboratory testing services for its Target SelectorTM NGS-based liquid biopsy targeted lung cancer panel to Quest patients. Quest Diagnostics is the world’s largest provider of diagnostic information services, which includes sophisticated diagnostics.

Some of the major players operating in the biopsy devices market are:

• BD, (U.S.),
• Cook (U.S.),
• Devicor Medical Products, Inc., (U.S),
• Leica Biosystems Nussloch GmbH (Germany),
• Argon Medical Devices Inc., (U.S.),
• B. Braun Melsungen AG (Germany),
• Cardinal Health (U.S.),
• Olympus Corporation (Japan),
• Boston Scientific Corporation (U.S.),
• FUJIFILM Holdings Corporation (Japan),
• INRAD, Inc. (U.S.), and
• Medtronic

Data Bridge Market Research